Recombinant Human PRKG1 Protein, N-His

Introduction to Recombinant Human PRKG1 Protein

Recombinant Human PRKG1 Protein, also known as cGMP-dependent protein kinase 1, is a crucial enzyme involved in various biological processes such as smooth muscle relaxation, platelet activation, and regulation of cell growth and differentiation. This protein is encoded by the PRKG1 gene and is a member of the protein kinase family. Recombinant Human PRKG1 Protein is produced through the process of recombinant DNA technology, making it a valuable tool for research and therapeutic applications.

Structure of Recombinant Human PRKG1 Protein

Recombinant Human PRKG1 Protein is a 78 kDa protein composed of 671 amino acids. It consists of three major domains: the N-terminal regulatory domain, the catalytic domain, and the C-terminal autoinhibitory domain. The regulatory domain contains two tandem cGMP-binding domains that are responsible for the activation of the protein. The catalytic domain contains the kinase activity of the protein, and the autoinhibitory domain regulates the kinase activity by interacting with the catalytic domain.

The structure of Recombinant Human PRKG1 Protein is highly conserved among different species, with 99% sequence identity between human and mouse PRKG1 proteins. This high level of conservation highlights the importance of this protein in various biological processes.

Activity of Recombinant Human PRKG1 Protein

Recombinant Human PRKG1 Protein is a serine/threonine kinase that is activated by the binding of cGMP to its regulatory domains. Upon activation, the protein phosphorylates its target proteins, leading to changes in their activity and function. One of the key targets of Recombinant Human PRKG1 Protein is myosin light chain, which is involved in smooth muscle relaxation.

Recombinant Human PRKG1 Protein also plays a crucial role in platelet activation and aggregation. It phosphorylates vasodilator-stimulated phosphoprotein (VASP), which regulates the assembly of actin filaments and controls the shape change and spreading of platelets. This process is essential for proper platelet aggregation and clot formation.

Moreover, Recombinant Human PRKG1 Protein has been shown to regulate cell growth and differentiation by modulating the activity of various transcription factors and signaling pathways. It has been implicated in the development of several diseases, including hypertension, cardiovascular diseases, and cancer.

Application of Recombinant Human PRKG1 Protein

Recombinant Human PRKG1 Protein has a wide range of applications in both research and therapeutic settings. In research, it is used to study the role of PRKG1 in different biological processes and to identify its target proteins. Recombinant Human PRKG1 Protein is also used in drug discovery and development, as it can be used to screen potential inhibitors or activators of the protein.

In the therapeutic field, Recombinant Human PRKG1 Protein has shown promising results in the treatment of cardiovascular diseases. It has been used as a potential therapy for pulmonary hypertension, a condition characterized by high blood pressure in the arteries of the lungs. Recombinant Human PRKG1 Protein has also been studied for its potential anti-cancer effects, as it has been shown to inhibit the growth and metastasis of certain types of cancer cells.

Conclusion

Recombinant Human PRKG1 Protein is a key enzyme involved in various biological processes, making it a valuable tool for research and therapeutic applications. Its structure, activity, and applications have been extensively studied, and it continues to be a subject of interest for scientists and researchers. With its potential to treat various diseases, Recombinant Human PRKG1 Protein holds great promise for future medical advancements.